StonvexLoading…
StonvexStonvexStonvexCore line items from KGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.31B | $1.16B | $850.38M | $707.91M |
Operating Income | $340.01M | $249.45M | $244.11M | $222.09M |
Net Income | $80.52M | $49.90M | $20.07M | $106.27M |
EPS (Diluted) | $0.89 | $0.56 | $0.29 | $1.80 |
Total Assets | $4.32B | $4.44B | $3.24B | $3.21B |
Total Liabilities | $3.11B | $3.06B | $2.10B | $2.98B |
Cash & Equivalents | $3.18M | $4.75M | $5.56M | $20.43M |
Free Cash Flow OCF − CapEx | $284.27M | $-8.97M | $46.53M | $-39.50M |
Shares Outstanding | 85.80M | 87.80M | 77.40M | 59.00M |